‘Female Viagra’ approved by US drug agency

addyi

The US Food and Drug Administration (FDA) has approved a libido-enhancing drug for women called the “female Viagra”. The drug, marketed as Addyi, has been criticised as having marginal benefits.

Unlike Viagra, which affects blood flow to the genitals, Addyi is designed to help women regain their sex drive by boosting levels of brain chemicals.

Viagra-like-drug-approved-in-U

Versions of the pill have been submitted for approval in the past but never passed.

It was rejected by the FDA twice for lack of effectiveness and side effects like nausea, dizziness and fainting.

The FDA said strict measures would be put in place to ensure patients were aware of the risks, including a warning not to drink alcohol with the drug.

It will be made available through certified health care professionals and pharmacies from October.

There will be warnings of the possible side effects, particularly for those with liver ailments, or if taken with certain other medicines, such as types of steroid.

Originally the drug was produced by German company Boehringer Ingelheim. Sprout bought the drug from that company after it was turned down by the FDA.

Sprout only has 25 employees. Large pharmaceutical companies like Pfizer, Bayer and Proctor & Gamble have all studied female sexual desire disorder treatment but abandoned plans to pursue it.

Sprout’s CEO, Cindy Whitehead, told Associated Press it would promote Addyi carefully.

Source: bbc/news

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s